Product Program year 2025 Source: CMS Open Payments

Vitesse

Device Oncology

PDI 00850800006012

Open in the dashboard

General payments

$10,030

19 payments

Research payments

$0

0 payments

Through program year 2025, $10,030 in general payments and $0 in research payments were reported against Vitesse (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $8,365 17
2024 General $1,665 2

Breakdown

Who paid General payments · program years 2024–2025
  1. Siemens Medical Solutions USA, Inc. $10,030 19 payments
Top recipients General payments · program year 2025
  1. Neil Taunk Radiation Oncology · Philadelphia, PA $3,095 37% · 6 payments
  2. Andrew Farach Radiation Oncology · Houston, TX $2,174 26% · 5 payments
  3. Yasmin Hasan Radiation Oncology · Chicago, IL $1,891 23% · 3 payments
  4. Anna Likhacheva Radiation Oncology · Gilbert, AZ $1,105 13% · 2 payments
  5. Ramiro Pino Radiological Physics · Houston, TX $100 1% · 1 payment

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Radiation Oncology Radiology $8,264 99% · 4 practitioners
  2. Radiological Physics Radiology $100 1% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Pennsylvania $3,095 37% · 1 recipient
  2. Texas $2,274 27% · 2 recipients
  3. Illinois $1,891 23% · 1 recipient
  4. Arizona $1,105 13% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

19 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record